Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 28, 2003. The report details a specific corporate action regarding share repurchases authorized by shareholders at the Annual General Meeting held on May 19, 2003.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to a specific share buyback transaction:
- Shares Purchased: 500,000 ordinary shares
- Purchase Price: 1,236.0218p per share
- Transaction Purpose: Cancellation of shares
Material Changes
The filing does not report material changes in operating results or financial position compared to prior periods. The primary event is the reduction of the company's share capital through the cancellation of 500,000 shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, contingencies, or discussion of unusual items beyond the execution of the authorized share repurchase.
Investor Verification Points
- Verify the total number of shares repurchased and cancelled under the May 19, 2003 authorization.
- Confirm the impact of this specific buyback on the company's total outstanding share count.
- Note that this filing does not contain quarterly or annual financial performance data.